Atlas Trials

Buspirone Therapy for Localized Epilepsy

Clinical trial NCT01496612 · TERMINATED

Trial details

NCT number
NCT01496612
Sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Anxiety DisorderSeizuresEpilepsyPartial EpilepsyDepression
Start date
2011-11-22
Primary completion
2016-04-19
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.